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Abstract
Background: A powdered ethanolic extract of Glycyrrhiza aspera root exhibits antimutagenic activity against
N-methyl-N-nitrosourea (MNU) based on the Ames assay with Salmonella typhimurium TA1535. The aim of this
study was to identify the antimutagenic components of the powdered ethanolic extract of G. aspera root.
Results: The powdered ethanolic extract of G. aspera root was sequentially suspended in n-hexane, carbon
tetrachloride, dichloromethane, ethyl acetate, and ethanol, and each solvent soluble fraction and the residue
were assayed for antimutagenic activity against MNU in S. typhimurium TA1535. The dichloromethane soluble
fraction exhibited the highest antimutagenicity and was fractionated several times by silica gel
chromatography. The fraction with the highest antimutagenic activity was further purified using HPLC, and
the fractions were assayed for antimutagenicity against MNU in S. typhimurium TA1535. Finally, five
components with antimutagenic activity against MNU were identified as glyurallin A, glyasperin B, licoricidin,
1-methoxyphaseollin, and licoisoflavone B.
Conclusions: The five components were demonstrated to possess an antigenotoxic effect against
carcinogenic MNU for the first time. It is important to prevent DNA damage by N-nitrosamines for cancer
chemoprevention.
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Background
Humans are exposed to endogenous and exogenous N-
nitroso compounds [1]. Approximately 45–75% of the
total human exposure to N-nitroso compounds is esti-
mated to be due to in vivo synthesis [2]. Almost all
tested N-nitroso compounds have carcinogenic activity
in experimental animals [1]. Therefore, exposure to N-
nitroso compounds is suspected to induce human can-
cer. Several epidemiological studies have demonstrated
that the endogenous formation of N-nitroso compounds
is correlated with the cancer incidence in humans [3–9].
Recently, the International Agency for Research on Can-
cer (IARC) has reported that the consumption of red
meat and processed meat is carcinogenic, and this may
be caused by N-nitroso compounds that form during
meat processing or cooking [10].
N-Methyl-N-nitrosourea (MNU) is a DNA alkylating
carcinogen that induces cancer in various organs,
particularly the forestomach, brain and nervous system,
in rodents [11]. MNU is produced by the nitrosation of
creatinine or fermented foods at the gastric pH [12–15].
Additionally, MNU is formed by the nitrosation of
methylurea with nitrite in guinea pig stomachs [16].
Therefore, for cancer chemoprevention, it is important
to identify compounds that can inhibit mutagenicity
induced by MNU.
Short-term bacterial mutation assays, such as the
Ames assay, are an effective screening tool for the
identification of various mutagenic or antimutagenic
compounds in complex materials [17]. The assay has
advantages as an inexpensive and flexible screening
method that provides preliminary information related to
antimutagenesis. There are many reports about the
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antimutagenicity of edible plants; however, the inhibitory
effects against MNU mutagenesis are less well studied
[18, 19].
Glycyrrhiza root has long been used worldwide as an
herbal medicine and natural sweetener [20–22]. The
genus Glycyrrhiza (Leguminosae) consists of about 30
species including G. glabra, G. uralensis, G. inflata, G.
aspera, G. korshinskyi and G. eurycarpa [23]. In Japanese
pharmacopeia, only G. glabra and G. uralensis are
permitted to be used as licorice and licorice powder, and
the other Glycyrrhiza species can be used as raw mate-
rials of licorice extract [23]. Glycyrrhiza has a reported
chemopreventive effect based on its anticarcinogenesis
and antimutagenesis toward both indirect-acting and
direct-acting mutagens [24–29]; however, the inhibitory
effects against MNU mutagenesis have not been studied
in detail.
In our previous study, a powdered ethanolic extract of
G. aspera root decreased MNU-induced mutagenicity in
a preliminary antimutagenic screen using the Ames
assay [30]. The aim of this study was to identify the anti-
mutagenic components of the powdered ethanolic
extract of G. aspera root.
Methods
General experimental procedures
The reaction progress was monitored using thin-layer
chromatography (TLC) on silica gel 60 F254 (0.25 mm,
Merck, Darmstadt, Germany). Column chromatography
was performed using silica gel 60 (0.04–0.063 mm,
Merck). Melting points were determined using a Yanaco
(Tokyo, Japan) micro-melting-point apparatus without
correction. HPLC was performed using an EYELA Pre-
parative LC system [VSP-3050 pump, UV-9000 spectro-
metric detector, LiChrosorb RP-18 column (10 μm,
25 mm × 300 mm)] (Tokyo Rikakikai Co. Ltd., Tokyo,
Japan) and a Shimadzu LC system [LC-6 AD pump,
SPD-20A UV spectrometric detector, Mightysil RP-18
column (5 μm, 20 mm × 250 mm)] (Kyoto, Japan). The
NMR spectra were recorded with a JEOL JNM-LA400
spectrometer (Tokyo, Japan). The chemical shifts were
expressed in ppm, downfield from TMS. The mass spec-
tra were collected using a JEOL JMS-SX102A mass spec-
trometer (Tokyo, Japan).
Reagents
Sodium ammonium hydrogen phosphate tetrahydrate
was purchased from Merck (Darmstadt, Germany).
Bacto agar and Bacto nutrient broth were obtained from
Becton Dickinson Microbiology Systems (Sparks, USA).
MNU were obtained from Toshin Gousei (Tokyo,
Japan). Other reagents were purchased from Wako Pure
Chemical Industries (Osaka, Japan). A powdered
ethanolic extract of G. aspera (China) root was kindly
provided by Tokiwa Phytochemical Co. Ltd. (Chiba,
Japan).
Preparation of a powdered ethanolic extracts of
Glycyrrhiza aspera root
A root of G. aspera (100 g) was refluxed with 95%
ethanolic aqueous solution (1000 mL) for 1 h, and the
mixture was filtered with suction. The residue was
refluxed again with 95% ethanolic aqueous solution
(1000 mL) for 1 h, and the mixture was filtered with
suction. The combined filtrates were concentrated under
reduced pressure and vacuum dried to a constant
weight, and finally a brown powder was obtained.
Fractionation of the powdered ethanolic extract of
Glycyrrhiza aspera root based on solubility in organic
solvents
The powered ethanolic extract of G. aspera root (10 g)
was added to hexane (100 mL) and stirred for 10 min.
The supernatant was filtered with suction. The stirring
and filtration of the residue was repeated twice. Sequen-
tially, the residue was suspended in carbon tetrachloride
(100 mL × 3), dichloromethane (100 mL × 3), ethyl
acetate (100 mL × 3), and ethanol (100 mL × 3) following
the same procedure. The organic solvent portions were
removed organic solvent by rotary evaporator and the
residue was dried in vacuo. The whole extraction
procedure was repeated twice; the organic portions and
residue were combined. Finally, hexane soluble fraction
(62 mg), carbon tetrachloride soluble fraction (880 mg),
dichloromethane soluble fraction (15.6 g), ethyl acetate
soluble fraction (11.4 g), ethanol soluble fraction
(700 mg) and the residue (1.7 g) were obtained from the
powdered ethanolic extract of G. aspera root (30 g).
Recovery of the weight was 101%.
Isolation of antimutagenic compounds from the
dichloromethane soluble fraction
The dichloromethane soluble fraction was chromato-
graphed on a silica gel, eluted with 5% methanol-CH2Cl2,
3% methanol-CH2Cl2, 1% methanol-CH2Cl2, 10% ethyl
acetate-CH2Cl2, and later separated on an RP-18 column
by preparative HPLC and eluted with 80% methanol in
water (see the Additional file 1). Five peaks representing
active components were purified using HPLC and charac-
terized by comparing their spectroscopic (NMR and MS)
properties with literature values.
Bacterial mutation assay
The antimutagenic effect of each plant extract was
assayed according to the Ames method using the plate-
incorporation protocol [31, 32]. Dr. T. Nohmi (National
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Institute of Health Sciences, Tokyo, Japan) kindly
provided the S. typhimurium TA1535.
A solution of MNU (1.5 μmol/50 μL DMSO) was
added to a test tube and supplemented with 0.1 M so-
dium phosphate buffer (pH 7.4, 0.5 mL), a solution
(50 μL) with various concentrations of fraction, and a
culture of the S. typhimurium TA1535 (0.1 mL), and the
solution was thoroughly mixed. Then, Top Agar (2 mL)
was added, and the mixture was poured onto a minimal-
glucose agar plate. The revertant colonies were counted
after incubation at 37 °C for 44 h. Each sample was
assayed using duplicate plates. The results are expressed
as the mean number of revertant colonies per plate.
Plates with neither MNU nor plant extract were consid-
ered negative controls. MNU (1.5 μmol/50 μL) resulted
in 1470 ± 70 colonies. All of the tested plates were
microscopically examined for thinning or the absence of
a background lawn and/or presence of microcolonies,
which are considered indicators of toxicity induced by
the test material. Neither MNU nor plant extracts dis-
played toxicity to S. typhimurium TA1535 under the
conditions of the antimutagenicity test.
Mutagenic activity in the presence of extracts is
expressed as the percentage of mutagenicity (% = Rs/R ×
100), where Rs is the number of his+ revertants/plate for
plates exposed to MNU and plants extracts, and R is the
number of his+ revertants/plate of MNU. The number
of spontaneous revertants was subtracted beforehand to
give Rs and R. Thus, the mutagenicity of MNU in the
absence of plant extracts was defined as 100% MNU
mutagenicity.
Cytotoxicity test
Toxicity assays under the same conditions as those used
for the Ames test were performed to determine the
maximum concentrations of plant extracts that could be
added without exerting toxic effects on the bacteria used
in the Ames test. A solution of MNU (1.5 μmol/50 μL
DMSO) was added to a test tube, and supplemented
with 0.1 M sodium phosphate buffer (pH 7.4, 0.5 mL),
each solution of plant extract (50 μL), and a culture of S.
typhimurium TA1535 (0.1 mL). A portion of the mixture
was diluted 105 times in 1/15 M PB. The diluted
solution (200 μL) was supplemented with histidine-free
Top Agar (2 mL) and poured on a Nutrient Broth agar
plate. The colonies were counted after incubation at 37 °
C for 20 h. Each sample was assayed using duplicate
plates. A substance was considered cytotoxic when the
bacterial survival was less than 80% of that observed in
the negative control. The mutation frequency was esti-
mated as the number of mutants per 107 surviving bac-
terial cells [31, 32].
Results and discussion
Identification of antimutagenic components from a
powdered ethanolic extract of Glycyrrhiza aspera root
A powdered ethanolic extract of G. aspera root was
sequentially suspended in n-hexane, carbon tetrachlor-
ide, dichloromethane, ethyl acetate, and ethanol. Each
soluble fraction and the residue were assayed for inhibi-
tory effects against MNU mutagenesis in Salmonella
typhimurium TA1535 (Fig. 1).
The dichloromethane soluble fraction showed the
highest antimutagenic activity, and was fractionated
using a silica gel column and preparative high-
performance liquid chromatography (HPLC), and its
antimutagenic components were identified. The fraction-
ation and mutagenicity assay were conducted repeatedly
(Fig. 2 and the Additional file 1). In each fractionation
step, the recoveries of weights were more than 89%.
Finally, the fraction (Fr.3-2-2-3-2) with the highest
antimutagenic activity was separated into fractions 1–9
using HPLC (Fig. 3a). Those fractions were tested for
mutagenicity against MNU, and the compounds from
peaks 4–8 each inhibited MNU-induced mutagenicity
(Fig. 3b)
Fig. 1 Effect of each soluble fraction on MNU-induced mutagenicity in S. typhimurium TA1535
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The compounds from fractions 4–8 were each analysed
using mass spectrometry and 1H nuclear magnetic reson-
ance spectroscopy, and five antimutagenic compounds
were identified, i.e., glyurallin A [33], glyasperin B [34],
licoricidin [35, 36], 1-methoxyphaseollin [37], and licoiso-
flavone B [38], by comparing their spectroscopic proper-
ties with literature values (Fig. 4).
Glyurallin A was a pterocarpene and 1-methoxyphaseollin
was a pterocarpan. Glyasperin B, licoricidin, and licoisofla-
vone B were an isoflavanone, an isoflavan, and an isoflavone,
respectively. A phenolic hydroxyl group is a common in five
isolated compounds with antimutagenicity.
Flavonoids are well-known antimutagens based on the
results of Ames assays [39, 40], whereas pterocarpenes
and pterocarpans are not well-known for their
antimutagenicity.
Inhibitory effect of licoricidin from the powdered
ethanolic extract of Glycyrrhiza aspera root on MNU-
induced mutagenicity
Licoricidin (peak 6) did not show any revertant colonies
by cytotoxicity (Fig. 3b). For the antimutagenicity assay,
it was necessary to determine the concentration at which
the viability of the tester strain did not decrease. Licori-
cidin reduced revertant colonies induced by MNU in S.
typhimurium TA1535 (Fig. 5a) without cytotoxicity at
the maximum concentration of 100 μg/plate (Fig. 5b).
To assess the precise antimutagenic potency of licorici-
din, mutation frequency was calculated by dividing the
number of mutants with the surviving fraction of bac-
teria (Fig. 5c). These data clearly showed that licoricidin
possessed antimutagenic activity against MNU in S.
typhimurium TA1535.
The antimutagenic activity of the G. glabra extract
against ethyl methanesulfonate (EMS) is reportedly
attributed to glabrene [41]. In our study, glabrene was
not isolated from the fraction with the highest muta-
genic activity. The difference between the isolated com-
pounds in antimutagenic activity for the powdered
ethanolic extract of G. aspera root probably reflects dif-
ferences in the mechanism of action between MNU and
EMS. MNU reacts mainly via an SN1 mechanism and ef-
ficiently alkylated both nitrogens and oxygens in DNA.
EMS, which reacts predominantly via an SN2 mechan-
ism, alkylates the nitrogens at the DNA bases and
produced little alkylation of the oxygens in DNA bases
[42, 43]. Thus, the MNU is far more mutagenic than
Fig. 2 Diagram of the separation procedure for the dichloromethane
soluble fraction
Fig. 3 a HPLC diagram of Fr. 3-2-2-3-2; b Effect of each fraction from Fr.3-2-2-3-2 on MNU-induced mutagenicity in S. typhimurium TA1535
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EMS. Additionally, the main bioactive components were
different between G. glabra and G. aspera [23].
In vitro, N-nitrosamine formation is inhibited by phen-
olic compounds, ascorbic acid, thiols, and metals [18,
19]. Mutagenesis by direct-acting mutagens can be
reduced or prevented in several ways; MNU can be
decomposed to non-mutagenic products via antimuta-
gens, or reactive mutagenic products from MNU can
react with antimutagens before reaching DNA. It is also
possible to induce repair enzymes in the Salmonella
strain [44].
A number of known flavonoids (such as genistein etc)
possess significant antimutagenic activity [40, 45, 46];
however, the detailed mechanism for the antimutageni-
city has not been completely established. The inhibitory
effect on the mutagenicity of direct-acting mutagens is
probably caused by a chemical reaction between the
mutagen and antimutagen. The inhibitory effect of
phenolic acid results from the scavenging action on an
electrophilic decomposition product of MNU [47]. Hung
et al have reported that hydroxylated flavonoids showed
antimutagenic activity toward benzo[a]pyrene 7,8-diol-
9,10-epoxide by direct interaction with the 7,8-diol-9,10-
epoxide [48]. Therefore, we assumed that the antimuta-
genic mechanisms of the isolated compounds were simi-
lar to that of phenolic acid or hydroxylated flavonoids.
Furthermore, MNU treatments are reported to induce
not only DNA alkylation but also increase intracellular
ROS level [49–51], and then the antimutagenicity was
partly attributed to its radical scavenging potency of fla-
vonoids [52–54]. We are working to elucidate the anti-
mutagenic mechanisms for the isolated compounds
against MNU.
Antimutagens and anticarcinogens in the diet are
suggested to be highly effective for cancer prevention
[44, 55, 56]. The intake of medicinal and edible plants
that include antimutagens may play a role in improving
human health.
Conclusions
It is important to prevent DNA damage by N-nitrosa-
mines for cancer chemoprevention. In this study, five
components with antimutagenic activity against MNU
from a powdered ethanolic extract of G. aspera root
were identified as glyurallin A, glyasperin B, licoricidin,
1-methoxyphaseollin, and licoisoflavone B. To the best
Fig. 4 Structures of antimutagenic agents from the powdered ethanolic extract of Glycyrrhiza aspera root
a b c
Fig. 5 Mutagenicity (a), survival rate (b), and mutation frequency (c) of licoricidin on MNU-induced mutagenicity in S. typhimurium TA1535
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of our knowledge, this report describes the first demon-
stration of the antigenotoxic effects of these components
against carcinogenic MNU.
Additional file
Additional file 1: Fractionations of antimutagenic compounds from
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